Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
Renato Tambucci,1 Claudia Basti,1 Maria Maresca,1 Giangennaro Coppola,2 Alberto Verrotti11Department of Pediatrics, University of L’Aquila, L’Aquila, Italy; 2Child and Adolescent Neuropsychiatry Unit, University of Salerno, Salerno, ItalyAbstract: Eslicarbazepine acetate...
Enregistré dans:
Auteurs principaux: | Tambucci R, Basti C, Maresca M, Coppola G, Verrotti A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/15e3e34c47e24dbfaef04045081c49bc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
par: Sunkaraneni S, et autres
Publié: (2017) -
EFFICACY OF BRIVARACETAM IN PEDIATRIC EPILEPSY: AN UP-TO-DATE
par: Antonio Nicotera
Publié: (2021) -
Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel
par: Edward Faught, et autres
Publié: (2021) -
An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients
par: Dozières-Puyravel B, et autres
Publié: (2019) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
par: Feyissa AM
Publié: (2019)